Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Forte Biosciences, Inc.

FBRX

HealthcareNASDAQUS

$16.52

-$0.17 (-1.02%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

FBRX

1Y-0.17 (-1.02%)

Candles, volume, SMA 20, and SMA 50

O 16.37H 16.7L 15.71C 16.52Date Jun 5

FBRX

SMA 20 SMA 50 Vol 408.71KEEarnings dates

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$229.39M

Volume?405.08K

Avg Volume?287.82K

52w Range$9.10 - $35.80

Beta?2.87

Price Performance

-36.9%

$26.17 to $16.52

YTD

-39.4%